Medical News

---

• Bipolar subtypes show neurobiologic differences
• Cannabis use linked to poorer cognition in dependent schizophrenia patients
• Bipolar subtypes show neurobiologic differences
• Cannabis use linked to poorer cognition in dependent schizophrenia patients
• ‘Sensory’ block promise for postop knee pain
• Personalized rectal cancer therapy shows promise
• US FDA approves raxibacumab for treating inhalational anthrax
• Long physical work does not greatly influence miscarriage risk
• Adiponectin flags up pancreatic cancer risk
• Enlarged lymph nodes may warn of cancer
• Personalized rectal cancer therapy shows promise
• Umbilical cord stem cell therapy shows promise in infant BPD

Bipolar subtypes show neurobiologic differences Posted: 19 Dec 2012 04:00 PM PST Results from a Taiwanese study show that there are significant neurobiologic differences between patients with bipolar I and II disorder.

Cannabis use linked to poorer cognition in dependent schizophrenia patients Posted: 19 Dec 2012 04:00 PM PST Cumulative cannabis use is negatively associated with cognition in men with schizophrenia who are currently dependent on the drug, report researchers.

Bipolar subtypes show neurobiologic differences Posted: 19 Dec 2012 04:00 PM PST Results from a Taiwanese study show that there are significant neurobiologic differences between patients with bipolar I and II disorder.

Cannabis use linked to poorer cognition in dependent schizophrenia patients Posted: 19 Dec 2012 04:00 PM PST Cumulative cannabis use is negatively associated with cognition in men with schizophrenia who are currently dependent on the drug, report researchers.

‘Sensory’ block promise for postop knee pain Posted: 18 Dec 2012 04:00 PM PST Using adductor canal block rather than femoral nerve block for analgesia after knee surgery could minimize muscle weakness and risk for falls, a study in Anesthesiology suggests.

Personalized rectal cancer therapy shows promise Posted: 18 Dec 2012 04:00 PM PST Personalized chemotherapy for rectal cancer results in high rates of pathologic response, indicate the results of a pilot study.

US FDA approves raxibacumab for treating inhalational anthrax Posted: 18 Dec 2012 04:00 PM PST The US Food and Drug Administration have approved the monoclonal antibody raxibacumab for treatment of inhalational anthrax, caused by breathing in spores of Bacillus anthracis.

Long physical work does not greatly influence miscarriage risk Posted: 18 Dec 2012 04:00 PM PST Results from a systematic review and meta-analysis suggest that fears about substantially increased miscarriage risks in women working shifts, long hours, and in jobs involving moderate-to-high physical workload may be largely unfounded.

Adiponectin flags up pancreatic cancer risk Posted: 18 Dec 2012 04:00 PM PST Circulating levels of adiponectin may provide a novel marker for identifying individuals who are at an increased risk for pancreatic cancer, report researchers.

Enlarged lymph nodes may warn of cancer Posted: 18 Dec 2012 04:00 PM PST Enlarged lymph nodes are a marker for both occult cancer and a long-term risk for malignancy, confirms research published in the British Journal of Haematology.

Personalized rectal cancer therapy shows promise Posted: 18 Dec 2012 04:00 PM PST Personalized chemotherapy for rectal cancer results in high rates of pathologic response, indicate the results of a pilot study.

Umbilical cord stem cell therapy shows promise in infant BPD Posted: 18 Dec 2012 04:00 PM PST Researchers have successfully used human umbilical cord stem cells to partially prevent damage and restore lung structure and function in an experimental animal model of bronchopulmonary dysplasia.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610